Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FIDO: Fixed Dose UFH vs LMWH for VTE
NCT00182403Phase 3Completed
- Sponsor
- McMaster University
- Start
- Sep 1998
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of heparin in venous thromboembolism (VTE), sponsored by McMaster University. Started Sep 1998; status: completed.
02
Drugs
heparin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00182403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00182403.